Theraclone Sciences Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Employees
-
22
- Latest Deal Type
-
Out of Business
Theraclone Sciences General Information
Description
Developer of therapeutic antibodies discovery platform intended to discover monoclonal antibodies. The company offers a comprehensive and right means to screen and identify rare antibodies produced naturally by human memory B cells in response to disease-causing agents, enabling medical practitioners to identify the rare antibodies produced by selected individuals to successfully ward off disease.
Contact Information
Website
www.theraclone-sciences.comCorporate Office
- 1124 Columbia Street
- Suite 300
- Seattle, WA 98104
- United States
Corporate Office
- 1124 Columbia Street
- Suite 300
- Seattle, WA 98104
- United States
Theraclone Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | Completed | Out of Business | ||||
| 4. Later Stage VC (Series C) | 30-Apr-2015 | Completed | Clinical Trials - Phase 3 | |||
| 3. Reverse Merger | 02-Dec-2013 | Cancelled | Clinical Trials - General | |||
| 2. Later Stage VC (Series B) | 12-Aug-2013 | $50M | $54.8M | Completed | Clinical Trials - General | |
| 1. Early Stage VC (Series A) | 24-Jan-2005 | $4.77M | $4.77M | Completed | Startup |
Theraclone Sciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B1 | ||||||||
| Series A1 | 4,225,734 | $0.001000 | $0.06 | $1 | $1 | 1x | $1 | 6.48% |
Theraclone Sciences Comparisons
Industry
Financing
Details
Theraclone Sciences Competitors (38)
One of Theraclone Sciences’s 38 competitors is Gennao, a Venture Capital-Backed company based in Pennington, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gennao | Venture Capital-Backed | Pennington, NJ | ||||
| Entrada Therapeutics | Formerly VC-backed | Boston, MA | ||||
| Vedanta Biosciences | Venture Capital-Backed | Cambridge, MA | ||||
| Navrogen | Venture Capital-Backed | Cheyney, PA | ||||
| Memo Therapeutics | Formerly VC-backed | Zurich, Switzerland |
Theraclone Sciences Patents
Theraclone Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140328797-A1 | Human rhinovirus (hrv) antibodies | Inactive | 01-May-2013 | ||
| AU-2014257289-A1 | Compositions and methods for the therapy and diagnosis of influenza | Inactive | 22-Apr-2013 | ||
| CA-2909802-A1 | Compositions and methods for the therapy and diagnosis of influenza | Inactive | 22-Apr-2013 | ||
| EP-2988781-A2 | Compositions and methods for the therapy and diagnosis of influenza | Inactive | 22-Apr-2013 | ||
| EP-2988781-A4 | Compositions and methods for the therapy and diagnosis of influenza | Inactive | 22-Apr-2013 | C07K16/108 |
Theraclone Sciences Signals
Theraclone Sciences Investments (1)
Theraclone Sciences’s most recent deal was a Joint Venture with OncoResponse. The deal was made on 18-Aug-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| OncoResponse | 18-Aug-2015 | Joint Venture | Drug Discovery |
Theraclone Sciences FAQs
-
When was Theraclone Sciences founded?
Theraclone Sciences was founded in 2005.
-
Where is Theraclone Sciences headquartered?
Theraclone Sciences is headquartered in Seattle, WA.
-
What is the size of Theraclone Sciences?
Theraclone Sciences has 22 total employees.
-
What industry is Theraclone Sciences in?
Theraclone Sciences’s primary industry is Drug Delivery.
-
Is Theraclone Sciences a private or public company?
Theraclone Sciences is a Private company.
-
What is Theraclone Sciences’s current revenue?
The current revenue for Theraclone Sciences is .
-
How much funding has Theraclone Sciences raised over time?
Theraclone Sciences has raised $59.2M.
-
Who are Theraclone Sciences’s competitors?
Gennao, Entrada Therapeutics, Vedanta Biosciences, Navrogen, and Memo Therapeutics are some of the 38 competitors of Theraclone Sciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process